Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult
Courtney M. Kenyon, BS,
Brenna G. Kelly, MD,
Anneli R. Bowen, MD,
Matthew Gumbleton, MD, PhD,
Dekker C. Deacon, MD, PhD
Affiliations
Courtney M. Kenyon, BS
University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, Utah
Brenna G. Kelly, MD
Department of Dermatology, University of Utah, Salt Lake City, Utah
Anneli R. Bowen, MD
Department of Dermatology, University of Utah, Salt Lake City, Utah
Matthew Gumbleton, MD, PhD
Division of Oncology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah; Huntsman Cancer Institute, Salt Lake City, Utah
Dekker C. Deacon, MD, PhD
Department of Dermatology, University of Utah, Salt Lake City, Utah; Huntsman Cancer Institute, Salt Lake City, Utah; Correspondence to: Dekker C. Deacon, MD, PhD, Department of Dermatology, University of Utah, 30 N. Mario Capecchi Dr, 1st Floor South, Salt Lake City, UT 84112.